Another is Asmanex, an asthma treatment that has yet to be approved by the U.S. Food and Drug Administration.
FORBES: Hassan Takes Over At Schering-Plough
Asmanex, a drug which has been approved in Europe but not the U.S., could be another growth driver should it get FDA approval.
FORBES: Magazine Article
应用推荐
模块上移
模块下移
不移动